Clinical Trial Update: Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating lenalidomide in combination with melphalan and dexamethasone for newly diagnos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Melphalan (Melphalan)

Snippet

Sponsor: Nantes University Hospital | Conditions: Amyloidosis | Phase 1, Phase 2 | Status: COMPLETED